Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 1;49(8):546-550.
doi: 10.1097/OLQ.0000000000001642. Epub 2022 May 16.

Cotesting for Human Immunodeficiency Virus and Sexually Transmitted Infections in the Emergency Department

Spencer S Seballos  1 , Rocio Lopez  2 , Fredric M Hustey  3 , Jesse D Schold  2 , Kamran Kadkhoda  4 , Adam J McShane  5 , Michael P Phelan  3
Affiliations

Cotesting for Human Immunodeficiency Virus and Sexually Transmitted Infections in the Emergency Department

Spencer S Seballos et al. Sex Transm Dis. .

Abstract

Background: The Centers for Disease Control and Prevention (CDC) and US Preventive Services Task Force (USPSTF) guidelines recommend screening for human immunodeficiency virus (HIV) in patients aged 15 to 65 years, as well as those at increased risk. Patients screened in the emergency department (ED) for gonorrhea (GC) and/or chlamydia represent an increased-risk population. Our aim was to assess compliance with CDC and USPSTF guidelines for HIV testing in a national sample of EDs.

Methods: We examined data from the 2010 to 2018 Nationwide Emergency Department Sample, which can be used to create national estimates of ED care to query tests for GC, chlamydia, HIV, and syphilis testing. Weighted proportions and 95% confidence intervals (CIs) were reported, and Rao-Scott χ 2 tests were used.

Results: We identified 13,443,831 (weighted n = 3,094,214) high-risk encounters in which GC/chlamydia testing was performed. HIV screening was performed in 3.9% (95% CI, 3.4-4.3) of such visits, and syphilis testing was performed in 2.9% (95% CI, 2.7-3.2). Only 1.5% of patients with increased risk encounters received both HIV and syphilis cotesting.

Conclusions: Despite CDC and USPSTF recommendations for HIV and syphilis screening in patients undergoing STI evaluation, only a small proportion of patients are being tested. Further studies exploring the barriers to HIV screening in patients undergoing STI assessment in the ED may help inform future projects aimed at increasing guidance compliance.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest and Sources of Funding: The authors all report no conflicts of interest to disclose. This study was unfunded.

References

    1. Dailey AF, Hoots BE, Hall HI, et al. Vital signs: Human immunodeficiency virus testing and diagnosis delays—United States. MMWR Morb Mortal Wkly Rep 2017; 66:1300–1306.
    1. Fauci AS, Redfield RR, Sigounas G, et al. Ending the HIV epidemic: A plan for the United States. JAMA 2019; 321:844–845.
    1. Weinstock HS, Kreisel KM, Spicknall IH, et al. STI prevalence, incidence, and costs in the United States: New estimates, new approach. Sex Transm Dis 2021; 48:207.
    1. Owens DK, Davidson KW, Krist AH, et al; US Preventive Services Task Force. Screening for HIV infection: US Preventive Services Task Force recommendation statement. JAMA 2019; 321:2326–2336.
    1. Workowski KA, Bolan GA; Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep 2015; 64(RR-03):1–137.